<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29787583</article-id><article-id pub-id-type="pmc">5963774</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0197852</article-id><article-id pub-id-type="publisher-id">PONE-D-17-21847</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Tendons</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Biological Tissue</subject><subj-group><subject>Connective Tissue</subject><subj-group><subject>Tendons</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject><subj-group><subject>Physical Fitness</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Sports Science</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject><subj-group><subject>Strength Training</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Materials Science</subject><subj-group><subject>Material Properties</subject><subj-group><subject>Mechanical Properties</subject><subj-group><subject>Stiffness</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Classical Mechanics</subject><subj-group><subject>Motion</subject><subj-group><subject>Torque</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Materials Science</subject><subj-group><subject>Material Properties</subject><subj-group><subject>Mechanical Properties</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Collagens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Ultrasound Imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Ultrasound Imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Ultrasound Imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Legs</subject><subj-group><subject>Knees</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Limbs (Anatomy)</subject><subj-group><subject>Legs</subject><subj-group><subject>Knees</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Gender associated muscle-tendon adaptations to resistance training</article-title><alt-title alt-title-type="running-head">Sex-specific muscle-tendon adaptations</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4852-9988</contrib-id><name><surname>McMahon</surname><given-names>Gerard</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Morse</surname><given-names>Christopher I.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Winwood</surname><given-names>Keith</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Burden</surname><given-names>Adrian</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Onamb&#x000e9;l&#x000e9;</surname><given-names>Gladys L.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>School of Sport, Ulster University, Belfast, United Kingdom</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Health, Exercise and Active Living (HEAL) Research Centre, Manchester Metropolitan University, Crewe, Cheshire, United Kingdom</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Csernoch</surname><given-names>Laszlo</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Debrecen, HUNGARY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>g.mcmahon@ulster.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>5</issue><elocation-id>e0197852</elocation-id><history><date date-type="received"><day>7</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>9</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 McMahon et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>McMahon et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0197852.pdf"/><abstract><sec id="sec001"><title>Purpose</title><p>To compare the relative changes in muscle-tendon complex (MTC) properties following high load resistance training (RT) in young males and females, and determine any link with circulating TGF&#x003b2;-1 and IGF-I levels.</p></sec><sec id="sec002"><title>Methods</title><p>Twenty-eight participants were assigned to a training group and subdivided by sex (T males [TM] aged 20&#x000b1;1 year, <italic>n</italic> = 8, T females [TF] aged 19&#x000b1;3 year, <italic>n</italic> = 8), whilst age-matched 6 males and 6 females were assigned to control groups (ConM/F). The training groups completed 8 weeks of resistance training (RT). MTC properties (Vastus Lateralis, VL) physiological cross-sectional area (pCSA), quadriceps torque, patella tendon stiffness [K], Young&#x02019;s modulus, volume, cross-sectional area, and length, circulating levels of TGF&#x003b2;-1 and IGF-I were assessed at baseline and post RT.</p></sec><sec id="sec003"><title>Results</title><p>Post RT, there was a significant increase in the mechanical and morphological properties of the MTC in both training groups, compared to ConM/F (p&#x0003c;0.001). However, there were no significant sex-specific changes in most MTC variables. There were however significant sex differences in changes in K, with females exhibiting greater changes than males at lower MVC (Maximal Voluntary Contraction) force levels (10% p = 0.030 &#x00026; 20% MVC p = 0.032) and the opposite effect seen at higher force levels (90% p = 0.040 &#x00026; 100% MVC p = 0.044). There were significant increases (p&#x0003c;0.05) in IGF-I in both TF and TM following training, with no change in TGF&#x003b2;-1. There were no gender differences (p&#x0003e;0.05) in IGF-I or TGF&#x003b2;-1. Interestingly, pooled population data showed that TGF&#x003b2;-1 correlated with K at baseline, with no correlations identified between IGF-I and MTC properties.</p></sec><sec id="sec004"><title>Conclusions</title><p>Greater resting TGF&#x003b2;-1 levels are associated with superior tendon mechanical properties. RT can impact opposite ends of the patella tendon force-elongation relationship in each sex. Thus, different loading patterns may be needed to maximize resistance training adaptations in each sex.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Institute for performance research</institution></funding-source><principal-award-recipient><name><surname>Onamb&#x000e9;l&#x000e9;</surname><given-names>Gladys L.</given-names></name></principal-award-recipient></award-group><funding-statement>The authors received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="14"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>The muscle-tendon complex (MTC) exhibits multiple physiological characteristics which differentially impact the physical capacities of males and females throughout the lifespan [<xref rid="pone.0197852.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0197852.ref003" ref-type="bibr">3</xref>] with young, exercising females possibly more susceptible to overuse injuries (such as tendinopathies) than males [<xref rid="pone.0197852.ref004" ref-type="bibr">4</xref>].</p><p>In particular, there is increasing evidence of sex-specific chronic adaptations of the in-series elastic component to resistance training (RT), over and above the intrinsic gender differences in both the absolute MTC properties at rest, and its acute response to exercise. Indeed, differences in viscoelastic properties of the free tendon and tendon-aponeurosis between young males and females have been demonstrated [<xref rid="pone.0197852.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0197852.ref007" ref-type="bibr">7</xref>], with females displaying lower stiffness, modulus, hysteresis and greater strain. The combination of data from previous studies [<xref rid="pone.0197852.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0197852.ref009" ref-type="bibr">9</xref>] highlight the difference in both resting and post-exercise tendon collagen fractional synthetic rate (FSR) between males and females, with FSR remaining significantly elevated 72 hours post 60 minutes leg-kicking, endurance type exercise in males. Further research has also shown that gender additionally influences the post resistance-exercise expression of tendon structural and extracellular matrix (ECM) regulatory components [<xref rid="pone.0197852.ref010" ref-type="bibr">10</xref>].</p><p>The sex difference in responsiveness to training in chronic response terms is highlighted in Westh et al.[<xref rid="pone.0197852.ref011" ref-type="bibr">11</xref>] who showed that long-term habitually trained young female runners displayed significantly lower tendon stiffness compared to similarly trained male runners. Interestingly however, these chronically trained female runners did not differ significantly in terms of tendon morphology or mechanical properties to female non-runners, which raises any questions with regards to any change in the intrinsic quality of the tendon with chronic training in females. It is also notable that sex differences have been demonstrated in the adaptability of MTC properties following an extended period of physical training in older individuals [<xref rid="pone.0197852.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0197852.ref013" ref-type="bibr">13</xref>], thereby emphasising the persistent nature of the superior responsiveness and adaptability in males. Whilst research strongly suggests that females demonstrate dissimilar relative adaption profiles to tendon mechanical stimuli compared to age-matched male counterparts, the adaptability and endocrine links associated with this observation following heavy load dynamic resistance training of tendon for instance, have yet to be elucidated.</p><p><italic>In vitro</italic> work suggests of particular importance to the endocrine adaptation of tendon, are growth factors Transforming Growth Factor Beta&#x02013; 1 (TGF&#x003b2;-1) and Insulin-Like Growth Factor One (IGF-I). Their primary roles in tendon include proliferation and migration of fibroblasts, subsequently increasing the production of collagens and other extracellular matrix structures in these cells during the remodelling stages [<xref rid="pone.0197852.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0197852.ref015" ref-type="bibr">15</xref>]. In humans [<xref rid="pone.0197852.ref016" ref-type="bibr">16</xref>] direct administration of IGF-I enhanced the collagen fractional synthetic rate in young and older males. In parallel, administration of IGF-I plus TGF&#x003b2;-1 together, significantly improved mechanical properties of rabbit tendon [<xref rid="pone.0197852.ref017" ref-type="bibr">17</xref>]. Recent work from Astill et al. [<xref rid="pone.0197852.ref018" ref-type="bibr">18</xref>] demonstrates that following an acute bout of RT, males and females both display significantly elevated IGF-I levels 3 hours post RT. However, only females had significantly elevated peritendinous levels of IGF-I at 4 hours post, whereas males did not. Additionally, males showed greater post-RT changes in Matrix Metallopeptidase 9 (MMP-9) levels than females, and females had a more prolonged exercise-induced elevations in tissue inhibitor of metalloproteinases-I (TIMP-I) than males.</p><p>Data shows no normative difference when comparing circulating TGF&#x003b2;-1 levels in males, pre and post-menopausal females, and pregnant females [<xref rid="pone.0197852.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0197852.ref020" ref-type="bibr">20</xref>]. Additionally, to the authors&#x02019; knowledge, there is no evidence to show that in a young, healthy population, there are marked fluctuations in systemic TGF&#x003b2;-1 levels [<xref rid="pone.0197852.ref021" ref-type="bibr">21</xref>]. At present, the literature on any link between the previously reported [<xref rid="pone.0197852.ref022" ref-type="bibr">22</xref>] acute <italic>in vivo</italic> TGF&#x003b2;-1 response to mechanical loading, and the magnitude or nature of human MTC training adaptations is limited. A topical study is that of Heinemeier et al. [<xref rid="pone.0197852.ref022" ref-type="bibr">22</xref>] who found elevation in systemic TGF&#x003b2;-1 levels (30%) following 1 hour of uphill (3%) treadmill running at 12kph in young persons, which the authors proposed may have been linked to the observed change in peri-tendon TGF&#x003b2;-1 levels and hence regulation of Type I collagen synthesis. However, in this Heinemeier et al.&#x02019;s study, the exercise protocol involved endurance running, and hence, arguably, a less than optimal training modality (compared to heavy resistance exercise) where the outcome aimed for is inducing MTC adaptations [<xref rid="pone.0197852.ref023" ref-type="bibr">23</xref>].</p><p>Taking the observed differences between sexes in MTC response/ adaptability to physical stimuli, no study to date has characterised the sex-specific adaptations of the MTC, following a period of heavy dynamic resistance training. In addition, it remains unclear whether any difference would be associated with major growth-factor candidates purported to influence MTC properties and adaptations to training. Therefore, the objectives of this study were to 1). Characterise the MTC adaptation to a period of dynamic, heavy-load resistance training in males and females, 2) identify any sex-related differences across MTC properties and 3) investigate whether any of the adaptive responses could be reflected in changes in two key circulating growth factors related to the MTC.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Methods</title><sec id="sec007"><title>Participants</title><p>Twenty-eight young participants recruited from the local university campus, gave written informed consent to participate in the study. All procedures and experimental protocols were approved by the Manchester Metropolitan University Cheshire Campus ethics committee. Exclusion criteria included the presence of any known musculoskeletal, neurological, inflammatory, or metabolic disorders or injury. Participants took part in recreational activities such as team sports and had either never taken part in lower limb resistance training or had not done so within the previous 12 months. Each participant completed a physical activity diary, outlining that they each habitually completed 3&#x02013;5 hours of non-resistance based moderate physical activity per week. Sixteen participants were then equally subdivided by sex and randomly assigned to a training group (T males [TM] age 20&#x000b1;1 years, mass 81&#x000b1;4Kg, T females [TF] age 19&#x000b1;3 years, mass 69&#x000b1;3Kg), whilst 6 males ([ConM] age 22&#x000b1;2 years, mass 82&#x000b1;2Kg) and 6 females ([ConF] age 23&#x000b1;4, mass 63&#x000b1;4Kg) were assigned to a control group (CON). All females were eumenorrheic (menstrual cycle duration of 26&#x02013;30 days) and none used any form of Oral Contraceptive Pill, the latter having been shown to impact of the MTC properties in females [<xref rid="pone.0197852.ref024" ref-type="bibr">24</xref>].</p></sec><sec id="sec008"><title>Study design</title><p>The study design was convenience sampling, with participants separated into groups according to sex followed by random allocation to one of two groups (i.e. training or control). Following familiarisation with laboratory procedures at least one week prior to testing proper, participants were assessed for MTC morphology/functional properties and growth factors at baseline (week 0). Measurements were repeated after 8 weeks resistance training (post-training).</p></sec><sec id="sec009"><title>Muscle physiological cross-sectional area (pCSA)</title><p>The measurement techniques used for the calculation for physiological cross-sectional area of the <italic>Vastus Lateralis</italic> (VL) muscle in the current study have been documented elsewhere [<xref rid="pone.0197852.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0197852.ref026" ref-type="bibr">26</xref>]. Briefly, multiple anatomical cross-sectional area (aCSA) measures were made via brightness mode ultrasonography (7.5-MHz, 40mm array probe, AU5, Esoate Biomedica, Genoa, Itlay) at 25%, 50% and 75% along the length of the VL muscle (insertion to origin), together with pennation angles and fascicle lengths. Muscle volume was then calculated using the truncated cone method, which has been validated in a number of previous studies [<xref rid="pone.0197852.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0197852.ref028" ref-type="bibr">28</xref>]. VL pCSA was calculated by dividing muscle volume by fascicle length [<xref rid="pone.0197852.ref028" ref-type="bibr">28</xref>].</p></sec><sec id="sec010"><title>Quadriceps torque</title><p>Maximal isometric knee extension torque was measured with the knee at 50&#x000b0; knee flexion (full knee extension = 0&#x000b0;) on the right leg of all participants. This angle was chosen to fall at 50% of the range of motion covered during the exercise routines, thereby minimising the effect of muscle length specificity on the reported muscle torque increments. After a series of warm up trials consisting of ten isokinetic contractions at 60&#x000b0;&#x000b7;s<sup>&#x02212;1</sup> at self-perceived 50&#x02013;85% maximal effort, participants were instructed to rapidly exert maximal isometric force (maximal voluntary contraction, MVC) against the dynamometer (Cybex, Phoenix Healthcare, UK) lever arm. Joint torque data traces were displayed on the screen of a MacBook Air computer (Apple Computer, Cupertino, CA, USA), which was interfaced with an A/D system (Acknowledge, Biopac Systems, Santa Barbara, CA, USA) with a sampling frequency of 2000 Hz. Isometric contractions were held for &#x0223c;2 s at the plateau with a 60 s rest period between contractions. Peak torque was expressed as the average of data points over a 500 ms period at the plateau phase (i.e. 250 ms either side of the instantaneous peak torque). The peak torque of three extensions was used as the measure of torque in each participant.</p></sec><sec id="sec011"><title>Estimation of co-contraction from electromyographical activity</title><p>A pair of Ag-AgCl electrodes (Neuroline 720, Ambu, Denmark), were placed on clean, shaved, and abraded skin, at 50% of femur length, in the mid-sagittal plane of the biceps femoris. The reference electrode (Blue sensor L, Ambu, Denmark) was placed on the lateral tibial condyle. The raw EMG signal was preamplified (MP100, Biopac Systems Inc., USA), amplified &#x000d7;1000 (MP100, Biopac Systems Inc., USA), bandpass filtered between 10&#x02013;500 Hz (Biopac Systems, USA) with a notch at 50Hz, and sampled at 2000 Hz. All EMG and torque signals were displayed in real time in AcqKnowledge software (Biopac systems Inc., USA) via a PC. Two maximal knee flexion contractions were carried out to obtain the EMG at maximal flexion torque. The root mean square (RMS) EMG activity was averaged for a 500ms period (average of 1.5ms moving windows) which coincided with the plateau of peak torque.</p><p>To reiterate, the EMG of the long head of the biceps femoris muscle was measured to ascertain the level of antagonist muscle co-contraction during the required isometric knee-extension performances. The biceps femoris torque during a knee-flexion contraction was calculated as described by McMahon et al. [<xref rid="pone.0197852.ref025" ref-type="bibr">25</xref>] whereby a linear relationship between BF EMG and torque is assumed, thus enabling the quantification of the &#x02018;pull back torque&#x02019; during knee extensions, and ultimately, the total forces experienced by the patella tendon [<xref rid="pone.0197852.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0197852.ref030" ref-type="bibr">30</xref>].</p></sec><sec id="sec012"><title>Tendon properties</title><p>The measures of tendon properties used in the current investigation have been described elsewhere [<xref rid="pone.0197852.ref031" ref-type="bibr">31</xref>]. Briefly, tendon elongation was determined using brightness mode ultrasound imaging over the apex of the patella in the sagittal plane, with the knee fixed at 90<sup>0</sup> flexion as per the norm in <italic>in vivo</italic> tendon properties assessment. Five preconditioning trials were carried out to ensure reproducibility. Following this, three ramped, 6-second isometric contractions were monitored for the distance between the original position of the tissue under the skin, relative to the new position of the tissue using ultrasound images captured onto a personal computer at 25 Hz. The ultrasound output was synchronized using a square wave signal generator to allow temporal alignment with both torque and EMG data. Tendon displacement was determined at intervals of 10% of the maximal force (from 10% to 100%) using image J. Three efforts were analysed, and the average reported as the profile of tendon force versus elongation for the participant. The plotted force&#x02013;elongation relationship was fitted with a second-order polynomial function, forced through zero. Instantaneous tendon stiffness (K) values were calculated from the slope of the tangents at 10% force intervals [<xref rid="pone.0197852.ref030" ref-type="bibr">30</xref>]. Mean tendon stiffness was the average stiffness value from 10&#x02013;100% MVC.</p><p>Patellar tendon (PT) resting length (TL) and cross-sectional area (Tcsa) were also assessed with the knee joint at 90<sup>o</sup> of flexion. TL was measured from the inferior pole of the patellar to the superior aspect of the tibial tuberosity determined from sagittal-plane ultrasound images. Tcsa was determined from the mean of transverse plane ultrasound images taken at 25%, 50%, and 75% TL. Young&#x02019;s modulus (E) was computed as instantaneous stiffness multiplied by the ratio of resting TL/Tcsa. Mean tendon stiffness was the average stiffness value from 10&#x02013;100% MVC.</p><p>PT volume (TVol) was calculated using the TL and Tcsa values along the length of the tendon using the truncated cone method, which used the same principles as those demonstrated on muscle volume assessments [<xref rid="pone.0197852.ref027" ref-type="bibr">27</xref>].</p></sec><sec id="sec013"><title>Circulating growth factor levels (IGF-I and TGF&#x003b2;-1)</title><p>Pre and post-training, following an overnight fast, (~10 hours), participants reported to the laboratory between 9-11am. 5 mL blood samples were collected from the antecubital vein of the forearm, placed in a crushed ice bed for 1.5 to 2-hours, and then centrifuged at 4&#x000b0;C for 10 min at 4,800 rpm, with the supernatant being removed and stored in at least two aliquots in eppendorfs at &#x02212;20&#x000b0; Celsius for later analysis. IGF-I and TGF&#x003b2;-1 were analysed using the standard enzyme-linked immuno-sorbent assay (ELISA) procedure, as described by McMahon et al. [<xref rid="pone.0197852.ref031" ref-type="bibr">31</xref>], with the overnight incubation for the first antibody binding phase option for the TGF&#x003b2;-1 (thereby increasing the sensitivity of the readings). Post-training samples were taken 3&#x02013;4 days post final training session, at the same time-of-day as the pre- training sampling for each participant.</p><p>The laboratory tests were timed to avoid diurnal variability or acute exercise-induced growth factor fluctuations.</p></sec><sec id="sec014"><title>Resistance training</title><p>Resistance training (RT) was performed three times per week for 8 weeks at 80% of 1 repetition maximum (1RM) on the knee extensor complex. Exercises included the back squat, leg press, leg extension (Technogym, Berkshire, UK), lunge, Bulgarian split squat and Sampson chair. All exercise sessions were supervised by a member of the research team. Participants completed two familiarisation sessions at 70%1RM prior to commencing the resistance training program. 1RMs were measured at baseline and every 2 weeks, with loading weight progressed. Volume (i.e. repetitions and sets) was identical for each training group, with each training session consisting of four exercises and performing three sets of 10 repetitions per exercise for the first 4 weeks, and four sets of eight repetitions per exercise thereafter. Training sessions would typically last ~60 minutes, with training records being diligently completed during sessions.</p></sec><sec id="sec015"><title>Statistics</title><p>Statistical analysis was carried out using IBM SPSS v19 (IBM Inc, USA). Data was analysed using a 4&#x000d7;2 ANCOVA with baseline measures used as covariates. The within-group factor was the phase of training (baseline, post-training) and the between-group factor was training group (i.e. TM, TF, ConM, ConF). Post-hoc comparisons are Bonferroni corrected and adjustments for multiple comparisons are applied in the correlation tables. All data are presented as mean &#x000b1; standard error of the mean (SEM). Statistical significance was set with alpha at &#x02264; 0.05. Power (&#x003b2;) and effect size (ES) are reported for those changes that exhibited significant sex differences, where power was calculated post hoc using the independent t-test assumptions. The sample size required to identify sex differences in the morphological and mechanical properties of the MTC was deemed adequate given that achieved study power was &#x02265;0.8.</p></sec></sec><sec sec-type="results" id="sec016"><title>Results</title><sec id="sec017"><title>Sex differences at baseline</title><p>There were no significant sex differences (p&#x0003e;0.05) in pCSA, Tvol, Tcsa, TL, PT K, PT E, TGF&#x003b2;-1 or IGF-I. As expected however, TM produced significantly (p&#x0003c;0.01) greater torque than TF.</p></sec><sec id="sec018"><title>MTC properties changes</title><p>There were significant increases in pCSA, strength, PT Vol, mean PT K and E, and IGF-I (<xref ref-type="table" rid="pone.0197852.t001">Table 1</xref>) in each training group, with no sex differences. However, when PT K was analysed at discrete force regions, significant sex-specific differences were identified (<xref ref-type="fig" rid="pone.0197852.g001">Fig 1</xref>). TF had significantly greater increments in stiffness compared to TM following training at lower MVC forces (10% (p = 0.030, &#x003b2; 0.94, ES 0.29) and 20%MVC (p = 0.032, &#x003b2; 0.93, ES 0.28)), whereas TM had significantly stiffer tendons compared to TF at higher MVC forces (90% (p = 0.040, &#x003b2; 0.92, ES 0.24) and 100% (p = 0.044, &#x003b2; 0.79, ES 0.26)). There were no changes in TGF&#x003b2;-1 in either the training groups (<xref ref-type="table" rid="pone.0197852.t001">Table 1</xref>), or either of the control groups at week 8 (p&#x0003e;0.05). There was a significant increase in IGF-I in both male and female training groups post-training (p&#x0003c;0.05), however there was no differences detected between the groups (p&#x0003e;0.05, <xref ref-type="table" rid="pone.0197852.t001">Table 1</xref>).</p><fig id="pone.0197852.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0197852.g001</object-id><label>Fig 1</label><caption><title>Relative changes in patella tendon stiffness (K) at each force level of the force-elongation curve.</title><p>Males (black bars) and females (white bars) following training. * Significant difference (P&#x0003c;0.05) between sex. Data are Mean &#x000b1; SEM.</p></caption><graphic xlink:href="pone.0197852.g001"/></fig><table-wrap id="pone.0197852.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0197852.t001</object-id><label>Table 1</label><caption><title>Baseline and post-training values for muscle-tendon complex properties and circulating growth factors in each gender.</title></caption><alternatives><graphic id="pone.0197852.t001g" xlink:href="pone.0197852.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Measure</th><th align="center" colspan="3" rowspan="1">Males (<italic>n</italic> = 8)</th><th align="center" colspan="3" rowspan="1">Females (<italic>n =</italic> 8)</th></tr><tr><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">Post-training</th><th align="center" rowspan="1" colspan="1">Change %</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">Post-training</th><th align="center" rowspan="1" colspan="1">Change</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>pCSA (cm</bold><sup><bold>2</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">71&#x000b1;4</td><td align="center" rowspan="1" colspan="1">87&#x000b1;7</td><td align="center" rowspan="1" colspan="1">24&#x000b1;9<xref ref-type="table-fn" rid="t001fn002">**</xref></td><td align="center" rowspan="1" colspan="1">40&#x000b1;3</td><td align="center" rowspan="1" colspan="1">52&#x000b1;5</td><td align="center" rowspan="1" colspan="1">30&#x000b1;10<xref ref-type="table-fn" rid="t001fn002">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Strength (Nm)</bold></td><td align="center" rowspan="1" colspan="1">223&#x000b1;25</td><td align="center" rowspan="1" colspan="1">254&#x000b1;10</td><td align="center" rowspan="1" colspan="1">26&#x000b1;18<xref ref-type="table-fn" rid="t001fn002">**</xref></td><td align="center" rowspan="1" colspan="1">145&#x000b1;11</td><td align="center" rowspan="1" colspan="1">177&#x000b1;10</td><td align="center" rowspan="1" colspan="1">25&#x000b1;6<xref ref-type="table-fn" rid="t001fn002">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>T Vol (cm</bold><sup><bold>3</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">5.91&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">6.35&#x000b1;0.45</td><td align="center" rowspan="1" colspan="1">8&#x000b1;4<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="center" rowspan="1" colspan="1">4.10&#x000b1;0.24</td><td align="center" rowspan="1" colspan="1">4.38&#x000b1;0.32</td><td align="center" rowspan="1" colspan="1">6&#x000b1;2<xref ref-type="table-fn" rid="t001fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mean PT K (N mm</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">1132&#x000b1;104</td><td align="center" rowspan="1" colspan="1">1517&#x000b1;138</td><td align="center" rowspan="1" colspan="1">35&#x000b1;4<xref ref-type="table-fn" rid="t001fn002">**</xref></td><td align="center" rowspan="1" colspan="1">619&#x000b1;72</td><td align="center" rowspan="1" colspan="1">887&#x000b1;108</td><td align="center" rowspan="1" colspan="1">46&#x000b1;11<xref ref-type="table-fn" rid="t001fn002">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Mean PT E (GPa)</bold></td><td align="center" rowspan="1" colspan="1">0.78&#x000b1;0.06</td><td align="center" rowspan="1" colspan="1">0.99&#x000b1;0.09</td><td align="center" rowspan="1" colspan="1">27&#x000b1;4<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="center" rowspan="1" colspan="1">0.42&#x000b1;0.04</td><td align="center" rowspan="1" colspan="1">0.60&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">46&#x000b1;16<xref ref-type="table-fn" rid="t001fn001">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>TGF&#x003b2;-1 (pg nL</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">5663&#x000b1;1524</td><td align="center" rowspan="1" colspan="1">4310&#x000b1;1248</td><td align="center" rowspan="1" colspan="1">-17&#x000b1;13</td><td align="center" rowspan="1" colspan="1">4716&#x000b1;1691</td><td align="center" rowspan="1" colspan="1">5276&#x000b1;2448</td><td align="center" rowspan="1" colspan="1">20&#x000b1;20</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>IGF-I (ng nL</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">392&#x000b1;90</td><td align="center" rowspan="1" colspan="1">431&#x000b1;26</td><td align="center" rowspan="1" colspan="1">13&#x000b1;9<xref ref-type="table-fn" rid="t001fn001">*</xref></td><td align="center" rowspan="1" colspan="1">380&#x000b1;24</td><td align="center" rowspan="1" colspan="1">460&#x000b1;42</td><td align="center" rowspan="1" colspan="1">23&#x000b1;9<xref ref-type="table-fn" rid="t001fn001">*</xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>* Significant difference compared to baseline (p&#x0003c;0.05)</p></fn><fn id="t001fn002"><p>** (p&#x0003c;0.01). Data are Mean &#x000b1; S.E.M. pCSA; Vastus Lateralis physiological Cross-sectional area, T Vol; Patella Tendon Volume, PT K; Patella Tendon Stiffness, PT E; Patella Tendon Modulus.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec019"><title>Associations between IGF-I and TGF&#x003b2;-1 against MTC characteristics</title><p>There was a significant positive correlation between mean tendon stiffness and TGF&#x003b2;-1 levels (r = 0.554; p = 0.026) in the pooled population at baseline. Baseline pooled (not sex specific) TGF&#x003b2;<italic>-1</italic> levels also correlated with baseline stiffness at some (30, 50 and 60% MVC) but not all torque levels (<xref ref-type="table" rid="pone.0197852.t002">Table 2</xref>). Pooled population week 8 TGF&#x003b2;<italic>-1</italic> levels correlated with baseline tendon stiffness at 10% through to 80% MVC. Pooled population baseline IGF-I values correlated with baseline stiffness at high force levels (i.e. from 60&#x02013;100% MVC) as well as correlating with average stiffness. At week 8 however, the correlations of IGF-I was in fact with lower force regions (i.e. 10&#x02013;50% MVC).</p><table-wrap id="pone.0197852.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0197852.t002</object-id><label>Table 2</label><caption><title>Differential gender associations between circulating TBG-&#x003b2;, IGF-I and Tendon K.</title></caption><alternatives><graphic id="pone.0197852.t002g" xlink:href="pone.0197852.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" colspan="2" rowspan="2">%MVC</th><th align="center" colspan="3" rowspan="1">TGF&#x003b2;-1 at Wk0</th><th align="center" colspan="3" rowspan="1">TGF&#x003b2;-1 at Wk8</th><th align="center" colspan="3" rowspan="1">IGF-I at Wk0</th><th align="center" colspan="3" rowspan="1">IGF-I at Wk8</th></tr><tr><th align="left" rowspan="1" colspan="1">M</th><th align="left" rowspan="1" colspan="1">F</th><th align="left" rowspan="1" colspan="1">P</th><th align="left" rowspan="1" colspan="1">M</th><th align="left" rowspan="1" colspan="1">F</th><th align="left" rowspan="1" colspan="1">P</th><th align="left" rowspan="1" colspan="1">M</th><th align="left" rowspan="1" colspan="1">F</th><th align="left" rowspan="1" colspan="1">P</th><th align="left" rowspan="1" colspan="1">M</th><th align="left" rowspan="1" colspan="1">F</th><th align="left" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">10%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">20%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">30%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">40%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">50%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">60%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">70%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x00394; K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">80%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Week 8 K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">90%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x00394; K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">100%</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x00394; K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">Average K</td><td align="left" rowspan="1" colspan="1">Baseline K</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Week 8 K</td><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x00394; K</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#808080" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Grey filled box denotes significant (p&#x0003c;0.05) correlation between circulating hormone level and force level variable in pooled (P), male (M) and female (F) populations. &#x00394; (delta) K, change in stiffness.</p></fn></table-wrap-foot></table-wrap><p>Our sex specific observations showed that in males, baseline TGF&#x003b2;-1 was associated with tendon stiffness at low forces (10&#x02013;60% MVC). Post-training TGF&#x003b2;-1 levels correlated significantly with post-training tendon stiffness at all force levels &#x0003e;30%MVC. Interestingly, TGF&#x003b2;-1 levels post-training also correlated with baseline tendon stiffness, although at more moderate force levels (10&#x02013;70%MVC). Whilst baseline IGF-I was not associated with tendon stiffness, at week 8, IGF-I levels correlated with week 8 stiffness at mid force levels (i.e. in the ranges of 20&#x02013;60%MVC) as well as correlating with mean stiffness.</p><p>In contrast to the findings in males, females&#x02019; baseline TGF&#x003b2;-1 did not correlate with stiffness at either baseline or post-training. Post-training TGF&#x003b2;-1 levels only correlated with post-training tendon stiffness at 80&#x02013;90% MVC. The only apparent/statistically significant relationships observed in females were with post-training IGF-I levels which correlated with baseline tendon stiffness at 40&#x02013;70%MVC and tendon stiffness at all force levels (10&#x02013;100% MVC) post-training.</p></sec></sec><sec sec-type="conclusions" id="sec020"><title>Discussion</title><p>Our key current findings are 1) we are the first to demonstrate sex-specificity in the overloading-induced adaptive nature of the mechanical properties of tendon in a young population. 2) Although TGF&#x003b2;-1 and IGF-I levels may not reflect the entirety of adaptation magnitude, they still appear to play an important role in chronic MTC characteristics. 3) High-load, dynamic resistance training may not be optimal to enhance MTC characteristics in females at higher portions of the tendon force-elongation curve.</p><p>Sex-related differences in the mechanical, structural and regulatory mechanisms in human tendinous tissue have been identified previously [<xref rid="pone.0197852.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0197852.ref007" ref-type="bibr">7</xref>]. Differences in acute tendon fractional collagen synthesis rates [<xref rid="pone.0197852.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0197852.ref009" ref-type="bibr">9</xref>], amount of tendon dry mass per wet tendon weight [<xref rid="pone.0197852.ref032" ref-type="bibr">32</xref>], mRNA levels of Type III collagen [<xref rid="pone.0197852.ref010" ref-type="bibr">10</xref>] have all been shown to vary between sexes. In addition, proteomic work from Little et al. [<xref rid="pone.0197852.ref033" ref-type="bibr">33</xref>] demonstrated that alcohol dehydrogenase 1B, MMP-3 and thrombosponsin-1 (TSP-1) are enriched in female patella tendons compared to male tendons, which suggests perhaps a reduced extra-cellular matrix regulatory or remodelling function, and alteration of mechanical properties in females. This would tend to suggest that, either at rest, or when provided with a similar physical stimulus to males, female tendon does not respond similarly. As successive acute responses to physical stimuli combine to produce the chronic adaptation, this leads to the possible scenario of a mal-adapted female tendon (i.e. morphologically or mechanically) relative to male tendon following a period of training.</p><sec id="sec021"><title>Morphology and mechanical properties</title><p>In the current study, we found that patella tendon volume significantly increased in both sexes by 8&#x000b1;4% and 6&#x000b1;2% in males and females respectively, with the small difference between sexes not being statistically significant. There were also no differences in the training-induced mean patella tendon stiffness change, between males and females. This is in contrast to the findings of Onambele-Pearson and Pearson [<xref rid="pone.0197852.ref012" ref-type="bibr">12</xref>] and Seynnes et al. [<xref rid="pone.0197852.ref013" ref-type="bibr">13</xref>] who found in older individuals (&#x0003e;70 years old), patella tendon stiffness changes in older males were significantly greater than that seen in older females following resistance-type and alpine skiing activities. What is interesting, in comparing the current investigation and the study of Onambele-Pearson and Pearson [<xref rid="pone.0197852.ref012" ref-type="bibr">12</xref>], is that both report the &#x02018;character&#x02019; or &#x02018;nature&#x02019; of tendon stiffness changes are inherently different between males and females following resistance training regardless of age. In their study, Onambele-Pearson and Pearson describe a &#x02018;cut-off point&#x02019; of ~40%MVC, where below this juncture, females exhibited their greatest changes in stiffness, and above it, males displayed their greater changes in stiffness. In a similar fashion, we describe here for the first time in a young population, that at force levels of 10&#x02013;20%MVC, and at 90&#x02013;100%MVC females have a significantly higher or lower RT-induced stiffness change respectively than males, with a cut-off at ~55%MVC (<xref ref-type="fig" rid="pone.0197852.g002">Fig 2</xref>). Although not immediately apparent why, one plausible explanation is that the tendon adapts to the loading requirements it most frequently encounters, which in respect to males&#x02019; tendons, is a lower absolute load in females. Evident from the torque data in the current study, the mean torque associated with the resistance training would have been much greater in males (post-training MVCs were 254&#x000b1;10 Nm vs. 177&#x000b1;10 Nm in males and females respectively and were significantly different at baseline), despite both groups training at the same relative load (but distinct absolute loads).</p><fig id="pone.0197852.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0197852.g002</object-id><label>Fig 2</label><caption><title>Normalized change in tendon stiffness to the mean stiffness change following training.</title><p>Males (black filled diamonds) and females (white filled squares).</p></caption><graphic xlink:href="pone.0197852.g002"/></fig></sec><sec id="sec022"><title>Resistance training program</title><p>A further potential physiological mechanism for our observations is the nature of the resistance training program. The exercises performed were dynamic (apart from one isometric), and isotonic in nature. Adaptations to eccentric training, such as microcirculatory factors and pain reduction, has been shown to be sex-specific in a cohort with Achilles tendinopathy, with males again demonstrating an improved responsiveness [<xref rid="pone.0197852.ref034" ref-type="bibr">34</xref>]. Furthermore, during maximal eccentric exercise between 20-90<sup>o</sup> knee extension, we previously [<xref rid="pone.0197852.ref007" ref-type="bibr">7</xref>] showed that female patella tendon displayed reduced stiffness compared to males, and attributed a large portion of the reduced fascicular lengthening seen in females compared to males to this observation. A subsequent study from our group [<xref rid="pone.0197852.ref035" ref-type="bibr">35</xref>] also showed that following the same exercise protocol, males displayed a significantly greater magnitude of muscle damage. This demonstrates that the sex-specific response and adaptations to variables associated with manipulating a resistance training program have yet to be elucidated, and await further study. Therefore, the results of the current study raises the following question: Is dynamic, heavy-load resistance training (currently the most conventional and popular form), the best training method for females routinely operating at the higher force levels of the tendon force-elongation curve, where adaptations to this type of training are minimised relative to adaptations on the subsequent lower portions of the tendon Force-Elongation curve?</p></sec><sec id="sec023"><title>Circulating IGF-I/ TGF&#x003b2;-1</title><p>A further novel aspect of the current investigation was to ascertain the changes to circulating growth factors related to tendon and ECM responses/adaptation. <italic>In vitro</italic> studies have demonstrated the potency of TGF&#x003b2;-1-mediated effects on collagen, and its relationship to magnitude of mechanical strain [<xref rid="pone.0197852.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0197852.ref015" ref-type="bibr">15</xref>]. Despite the vast array of data from <italic>in vitro</italic> studies outlining the roles of TGF&#x003b2;-1 in tendon and ECM maintenance/ repair, data from <italic>in vivo</italic> human exercise studies is scarce. What is also surprising is that to date, only one study had previously described the effect of resistance training as opposed to endurance kicking-type exercise, on TGF&#x003b2;-1 and tendon mechanical properties, despite resistance training being a more potent mechanical stimulus for tendon adaptation. We have also previously shown in a young population [<xref rid="pone.0197852.ref031" ref-type="bibr">31</xref>], that resistance training did not result in chronically elevated TGF&#x003b2;-1 levels following 8 weeks of heavy resistance training with varying levels of strain. This was also the case in the current study, where there were no significant changes in either males or females following resistance training, despite significant improvements in tendon mechanical properties. Although a ~30% post-exercise increase in circulating TGF&#x003b2;-1 associated with increased local Type I collagen synthesis and peri-tendinous TGF&#x003b2;-1 levels has been documented [<xref rid="pone.0197852.ref022" ref-type="bibr">22</xref>], it may be that TGF&#x003b2;-1 does not remain chronically elevated to maintain a healthy (non-fibrotic) connective tissue profile. Thus, within the confines of the current study&#x02019;s experimental design, measurement of pre-and post-8 weeks of resistance training may not have been facilitative in uncovering TGF&#x003b2;-1&#x02019;s mechanistic role. Despite this, we have shown a strong, positive correlation between baseline TGF&#x003b2;-1 levels and tendon stiffness. This would make sense, from the point that a natural higher physiological level of TGF&#x003b2;-1 could produce and preserve a stiffer MTC. Previous research has shown, lower levels of TGF&#x003b2;-1 and dysregulation of the TGF-&#x003b2; axis are present in diseased compared to healthy tendons [<xref rid="pone.0197852.ref036" ref-type="bibr">36</xref>]. It should nonetheless be noted that measuring TGF&#x003b2;-1 in blood is a complex issue, with many large variations measured between studies. However, in a young, healthy population, such as in the current study, there have been shown to be no differences between male and females in circulating TGF&#x003b2;-1 levels [<xref rid="pone.0197852.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0197852.ref020" ref-type="bibr">20</xref>]. Furthermore, our reported circulating TGF&#x003b2;-1 levels are consistent with previously published data in a review using the same ELISA kit (R&#x00026;D systems) and a robust TGF&#x003b2;-1 sampling methodology [<xref rid="pone.0197852.ref020" ref-type="bibr">20</xref>].</p><p>IGF-I levels increased significantly as a result of heavy resistance training in both sexes. Similar observations have also been made, with peritendinous levels of IGF-I being significantly elevated at 3 hours post-RT in both males and females, but in females only, remaining elevated at 4 hours post RT [<xref rid="pone.0197852.ref018" ref-type="bibr">18</xref>]. In a patella tendon defect model in rabbits, direct administration of IGF-I and TGF&#x003b2;-1 together significantly improved the mechanical properties of tendon such as force at failure, ultimate stress and stiffness [<xref rid="pone.0197852.ref017" ref-type="bibr">17</xref>]. Results from the studies of Doessing and co-workers [<xref rid="pone.0197852.ref037" ref-type="bibr">37</xref>] and Nielson et al. [<xref rid="pone.0197852.ref016" ref-type="bibr">16</xref>] demonstrate that IGF-I, and the regulatory function of the growth hormone/ IGF-I axis, are important factors for the matrix collagen fractional synthetic rate, expression of Type I collagen and tendon function. Circulating levels of IGF-I do not allow distinction between effects on muscle and/or tendon. In the current study, males and females showed very similar relative changes in IGF-I, muscle size, torque, tendon volume and tendon mechanical properties. IGF-I thus may have played a role in the adaptive process, with the work of Doessing et al. [<xref rid="pone.0197852.ref037" ref-type="bibr">37</xref>] suggesting that IGF-I may play a more prominent role in tendinous as opposed to muscular adaptation.</p></sec><sec id="sec024"><title>Practical application</title><p>It has been suggested that young, exercising females are possibly at more risk of tendon injury than males [<xref rid="pone.0197852.ref004" ref-type="bibr">4</xref>]. The practical implications of the current study are that females operating toward the maximal end of the MVC spectrum, may experience a relatively reduced enhancement of tendon stiffness following RT. A sex-specific electromechanical delay has been noted previously [<xref rid="pone.0197852.ref038" ref-type="bibr">38</xref>], with females showing an increased delay compared to males. In parallel, we have also previously demonstrated that during maximal eccentric contractions [<xref rid="pone.0197852.ref007" ref-type="bibr">7</xref>], there are sex differences in absolute patella tendon stiffness, which in turn modulated <italic>Vastus Lateralis</italic> fascicle lengthening, affecting force production. These above facts compound the evidence and necessity to consider sex difference in resistance training applications. Therefore, female athletes involved in sprint/power activities may find that transfer of contractile force to bone during a high-force effort may be compromised in terms of amount of force and/ or rate of force development due to sub-optimal changes in stiffness, or indeed reduced force development due to modulation of the fascicular shortening. Therefore, future studies may wish to focus on elucidating methods to increase stiffness at higher MVC forces in young, female populations.</p></sec><sec id="sec025"><title>Conclusion</title><p>In conclusion, we have demonstrated that both males and females display the same relative adaptability in terms of enhancing muscle-tendon morphology and function following resistance training. However, the nature of these adaptations have implications for muscle-tendon function during different tasks for each sex. Finally, for females, high-load dynamic resistance training may not be optimal for enhancing MTC function at high force outputs.</p></sec></sec><sec sec-type="supplementary-material" id="sec026"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0197852.s001"><label>S1 File</label><caption><title>Muscle-tendon male and female raw data results.</title><p>(XLSX)</p></caption><media xlink:href="pone.0197852.s001.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0197852.s002"><label>S2 File</label><caption><title>Endocrine growth factors regressions.</title><p>(XLSX)</p></caption><media xlink:href="pone.0197852.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors wish to thank the study participants for their commitment to the training program.</p></ack><ref-list><title>References</title><ref id="pone.0197852.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Sipil&#x000e4;</surname><given-names>S</given-names></name>, <name><surname>Narici</surname><given-names>M</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>, <name><surname>P&#x000f6;ll&#x000e4;nen</surname><given-names>E</given-names></name>, <name><surname>Atkinson</surname><given-names>RA</given-names></name>, <name><surname>Hansen</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Sex hormones and skeletal muscle weakness</article-title>. <source>Biogerontology</source>. <year>2013</year>;<volume>14</volume>(<issue>3</issue>):<fpage>231</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10522-013-9425-8">10.1007/s10522-013-9425-8</ext-link></comment>
<pub-id pub-id-type="pmid">23636830</pub-id></mixed-citation></ref><ref id="pone.0197852.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Hansen</surname><given-names>M</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>. <article-title>Influence of sex and estrogen on musculotendinous protein turnover at rest and after exercise</article-title>. <source>Exerc Sport Sci Rev</source>. <year>2014</year>;<volume>42</volume>(<issue>4</issue>):<fpage>183</fpage>&#x02013;<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1249/JES.0000000000000026">10.1249/JES.0000000000000026</ext-link></comment>
<pub-id pub-id-type="pmid">25062001</pub-id></mixed-citation></ref><ref id="pone.0197852.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>FW</given-names></name>, <name><surname>Smith</surname><given-names>PA</given-names></name>. <article-title>Musculoskeletal differences between males and females</article-title>. <source>Sports Medicine and Arthroscopy Review</source>. <year>2002</year>;<volume>10</volume>(<issue>1</issue>):<fpage>98</fpage>&#x02013;<lpage>100</lpage>.</mixed-citation></ref><ref id="pone.0197852.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Maffulli</surname><given-names>N</given-names></name>, <name><surname>Wong</surname><given-names>J</given-names></name>, <name><surname>Almekinders</surname><given-names>LC</given-names></name>. <article-title>Types and epidemiology of tendinopathy</article-title>. <source>Clin Sports Med</source>. <year>2003</year>;<volume>22</volume>(<issue>4</issue>):<fpage>675</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="pmid">14560540</pub-id></mixed-citation></ref><ref id="pone.0197852.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Kubo</surname><given-names>K</given-names></name>, <name><surname>Kanehisa</surname><given-names>H</given-names></name>, <name><surname>Fukunaga</surname><given-names>T</given-names></name>. <article-title>Gender differences in the viscoelastic properties of tendon structures</article-title>. <source>European Journal of Applied Physiology</source>. <year>2003</year>;<volume>88</volume>(<issue>6</issue>):<fpage>520</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00421-002-0744-8">10.1007/s00421-002-0744-8</ext-link></comment>
<pub-id pub-id-type="pmid">12560950</pub-id></mixed-citation></ref><ref id="pone.0197852.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Onambele</surname><given-names>GN</given-names></name>, <name><surname>Burgess</surname><given-names>K</given-names></name>, <name><surname>Pearson</surname><given-names>SJ</given-names></name>. <article-title>Gender-specific in vivo measurement of the structural and mechanical properties of the human patellar tendon</article-title>. <source>J Orthop Res</source>. <year>2007</year>;<volume>25</volume>(<issue>12</issue>):<fpage>1635</fpage>&#x02013;<lpage>42</lpage>. Epub 2007/06/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jor.20404">10.1002/jor.20404</ext-link></comment> .<pub-id pub-id-type="pmid">17568426</pub-id></mixed-citation></ref><ref id="pone.0197852.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Hicks</surname><given-names>K</given-names></name>, <name><surname>Onambele&#x02010;Pearson</surname><given-names>G</given-names></name>, <name><surname>Winwood</surname><given-names>K</given-names></name>, <name><surname>Morse</surname><given-names>C</given-names></name>. <article-title>Gender differences in fascicular lengthening during eccentric contractions: the role of the patella tendon stiffness</article-title>. <source>Acta physiologica</source>. <year>2013</year>;<volume>209</volume>(<issue>3</issue>):<fpage>235</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/apha.12159">10.1111/apha.12159</ext-link></comment>
<pub-id pub-id-type="pmid">23964725</pub-id></mixed-citation></ref><ref id="pone.0197852.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>BF</given-names></name>, <name><surname>Hansen</surname><given-names>M</given-names></name>, <name><surname>Olesen</surname><given-names>JL</given-names></name>, <name><surname>Schwarz</surname><given-names>P</given-names></name>, <name><surname>Babraj</surname><given-names>JA</given-names></name>, <name><surname>Smith</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Tendon collagen synthesis at rest and after exercise in women</article-title>. <source>J Appl Physiol</source>. <year>2007</year>;<volume>102</volume>(<issue>2</issue>):<fpage>541</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00797.2006">10.1152/japplphysiol.00797.2006</ext-link></comment>
<pub-id pub-id-type="pmid">16990502</pub-id></mixed-citation></ref><ref id="pone.0197852.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>BF</given-names></name>, <name><surname>Olesen</surname><given-names>JL</given-names></name>, <name><surname>Hansen</surname><given-names>M</given-names></name>, <name><surname>D&#x000f8;ssing</surname><given-names>S</given-names></name>, <name><surname>Crameri</surname><given-names>RM</given-names></name>, <name><surname>Welling</surname><given-names>RJ</given-names></name>, <etal>et al</etal>
<article-title>Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise</article-title>. <source>The Journal of physiology</source>. <year>2005</year>;<volume>567</volume>(<issue>3</issue>):<fpage>1021</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">16002437</pub-id></mixed-citation></ref><ref id="pone.0197852.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Sullivan</surname><given-names>BE</given-names></name>, <name><surname>Carroll</surname><given-names>CC</given-names></name>, <name><surname>Jemiolo</surname><given-names>B</given-names></name>, <name><surname>Trappe</surname><given-names>SW</given-names></name>, <name><surname>Magnusson</surname><given-names>SP</given-names></name>, <name><surname>D&#x000f8;ssing</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Effect of acute resistance exercise and sex on human patellar tendon structural and regulatory mRNA expression</article-title>. <source>J Appl Physiol</source>. <year>2009</year>;<volume>106</volume>(<issue>2</issue>):<fpage>468</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.91341.2008">10.1152/japplphysiol.91341.2008</ext-link></comment>
<pub-id pub-id-type="pmid">19023016</pub-id></mixed-citation></ref><ref id="pone.0197852.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Westh</surname><given-names>E</given-names></name>, <name><surname>Kongsgaard</surname><given-names>M</given-names></name>, <name><surname>Bojsen&#x02010;Moller</surname><given-names>J</given-names></name>, <name><surname>Aagaard</surname><given-names>P</given-names></name>, <name><surname>Hansen</surname><given-names>M</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Effect of habitual exercise on the structural and mechanical properties of human tendon, in vivo, in men and women</article-title>. <source>Scand J Med Sci Sports</source>. <year>2008</year>;<volume>18</volume>(<issue>1</issue>):<fpage>23</fpage>&#x02013;<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1600-0838.2007.00638.x">10.1111/j.1600-0838.2007.00638.x</ext-link></comment>
<pub-id pub-id-type="pmid">17490462</pub-id></mixed-citation></ref><ref id="pone.0197852.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Onambele-Pearson</surname><given-names>GL</given-names></name>, <name><surname>Pearson</surname><given-names>SJ</given-names></name>. <article-title>The magnitude and character of resistance-training-induced increase in tendon stiffness at old age is gender specific</article-title>. <source>Age</source>. <year>2012</year>;<volume>34</volume>(<issue>2</issue>):<fpage>427</fpage>&#x02013;<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11357-011-9248-y">10.1007/s11357-011-9248-y</ext-link></comment>
<pub-id pub-id-type="pmid">21505764</pub-id></mixed-citation></ref><ref id="pone.0197852.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Seynnes</surname><given-names>OR</given-names></name>, <name><surname>Koesters</surname><given-names>A</given-names></name>, <name><surname>Gimpl</surname><given-names>M</given-names></name>, <name><surname>Reifberger</surname><given-names>A</given-names></name>, <name><surname>Niederseer</surname><given-names>D</given-names></name>, <name><surname>Niebauer</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Effect of alpine skiing training on tendon mechanical properties in older men and women</article-title>. <source>Scand J Med Sci Sports</source>. <year>2011</year>;<volume>21</volume>:<fpage>39</fpage>&#x02013;<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1600-0838.2011.01340.x">10.1111/j.1600-0838.2011.01340.x</ext-link></comment>
<pub-id pub-id-type="pmid">21679322</pub-id></mixed-citation></ref><ref id="pone.0197852.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Molloy</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Murrell</surname><given-names>GAC</given-names></name>. <article-title>The roles of growth factors in tendon and ligament healing</article-title>. <source>Sports Med</source>. <year>2003</year>;<volume>33</volume>(<issue>5</issue>):<fpage>381</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="pmid">12696985</pub-id></mixed-citation></ref><ref id="pone.0197852.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>G</given-names></name>, <name><surname>Crawford</surname><given-names>RC</given-names></name>, <name><surname>Wang</surname><given-names>JHC</given-names></name>. <article-title>Proliferation and collagen production of human patellar tendon fibroblasts in response to cyclic uniaxial stretching in serum-free conditions</article-title>. <source>J Biomech</source>. <year>2004</year>;<volume>37</volume>(<issue>10</issue>):<fpage>1543</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jbiomech.2004.01.005">10.1016/j.jbiomech.2004.01.005</ext-link></comment>
<pub-id pub-id-type="pmid">15336929</pub-id></mixed-citation></ref><ref id="pone.0197852.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Nielsen</surname><given-names>RH</given-names></name>, <name><surname>Holm</surname><given-names>L</given-names></name>, <name><surname>Malmgaard-Clausen</surname><given-names>NM</given-names></name>, <name><surname>Reitelseder</surname><given-names>S</given-names></name>, <name><surname>Heinemeier</surname><given-names>KM</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>. <article-title>Increase in tendon protein synthesis in response to insulin-like growth factor-I is preserved in elderly men</article-title>. <source>J Appl Physiol</source>. <year>2014</year>;<volume>116</volume>(<issue>1</issue>):<fpage>42</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.01084.2013">10.1152/japplphysiol.01084.2013</ext-link></comment>
<pub-id pub-id-type="pmid">24265284</pub-id></mixed-citation></ref><ref id="pone.0197852.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Lyras</surname><given-names>DN</given-names></name>, <name><surname>Kazakos</surname><given-names>K</given-names></name>, <name><surname>Verettas</surname><given-names>D</given-names></name>, <name><surname>Chronopoulos</surname><given-names>E</given-names></name>, <name><surname>Folaranmi</surname><given-names>S</given-names></name>, <name><surname>Agrogiannis</surname><given-names>G</given-names></name>. <article-title>Effect of combined administration of transforming growth factor-b1 and insulin-like growth factor I on the mechanical properties of a patellar tendon defect model in rabbits</article-title>. <source>Acta Orthop Belg</source>. <year>2010</year>;<volume>76</volume>(<issue>3</issue>):<fpage>380</fpage>
<pub-id pub-id-type="pmid">20698461</pub-id></mixed-citation></ref><ref id="pone.0197852.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Astill</surname><given-names>BD</given-names></name>, <name><surname>Katsma</surname><given-names>MS</given-names></name>, <name><surname>Cauthon</surname><given-names>DJ</given-names></name>, <name><surname>Greenlee</surname><given-names>J</given-names></name>, <name><surname>Murphy</surname><given-names>M</given-names></name>, <name><surname>Curtis</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Sex-based difference in Achilles peritendinous levels of matrix metalloproteinases and growth factors after acute resistance exercise</article-title>. <source>J Appl Physiol</source>. <year>2017</year>;<volume>122</volume>(<issue>2</issue>):<fpage>361</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00878.2016">10.1152/japplphysiol.00878.2016</ext-link></comment>
<pub-id pub-id-type="pmid">27881671</pub-id></mixed-citation></ref><ref id="pone.0197852.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Wakefield</surname><given-names>LM</given-names></name>, <name><surname>Letterio</surname><given-names>JJ</given-names></name>, <name><surname>Chen</surname><given-names>T</given-names></name>, <name><surname>Danielpour</surname><given-names>D</given-names></name>, <name><surname>Allison</surname><given-names>R</given-names></name>, <name><surname>Pai</surname><given-names>LH</given-names></name>, <etal>et al</etal>
<article-title>Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer</article-title>. <source>Clin Cancer Res</source>. <year>1995</year>;<volume>1</volume>(<issue>1</issue>):<fpage>129</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="pmid">9815895</pub-id></mixed-citation></ref><ref id="pone.0197852.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Grainger</surname><given-names>DJ</given-names></name>, <name><surname>Mosedale</surname><given-names>DE</given-names></name>, <name><surname>Metcalfe</surname><given-names>JC</given-names></name>. <article-title>TGF-&#x003b2; in blood: a complex problem</article-title>. <source>Cytokine Growth Factor Rev</source>. <year>2000</year>;<volume>11</volume>(<issue>1</issue>):<fpage>133</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">10708961</pub-id></mixed-citation></ref><ref id="pone.0197852.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Heinemeier</surname><given-names>K</given-names></name>, <name><surname>Langberg</surname><given-names>H</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>. <article-title>Exercise-induced changes in circulating levels of transforming growth factor-&#x003b2;-1 in humans: methodological considerations</article-title>. <source>European Journal of Applied Physiology</source>. <year>2003</year>;<volume>90</volume>(<issue>1&#x02013;2</issue>):<fpage>171</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00421-003-0881-8">10.1007/s00421-003-0881-8</ext-link></comment>
<pub-id pub-id-type="pmid">14504950</pub-id></mixed-citation></ref><ref id="pone.0197852.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Heinemeier</surname><given-names>K</given-names></name>, <name><surname>Langberg</surname><given-names>H</given-names></name>, <name><surname>Olesen</surname><given-names>JL</given-names></name>, <name><surname>Kjaer</surname><given-names>M</given-names></name>. <article-title>Role of TGF-&#x003b2;1 in relation to exercise-induced type I collagen synthesis in human tendinous tissue</article-title>. <source>J Appl Physiol</source>. <year>2003</year>;<volume>95</volume>(<issue>6</issue>):<fpage>2390</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00403.2003">10.1152/japplphysiol.00403.2003</ext-link></comment>
<pub-id pub-id-type="pmid">12923117</pub-id></mixed-citation></ref><ref id="pone.0197852.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Albracht</surname><given-names>K</given-names></name>, <name><surname>Arampatzis</surname><given-names>A</given-names></name>. <article-title>Exercise-induced changes in triceps surae tendon stiffness and muscle strength affect running economy in humans</article-title>. <source>European Journal of Applied Physiology</source>. <year>2013</year>;<volume>113</volume>(<issue>6</issue>):<fpage>1605</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00421-012-2585-4">10.1007/s00421-012-2585-4</ext-link></comment>
<pub-id pub-id-type="pmid">23328797</pub-id></mixed-citation></ref><ref id="pone.0197852.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Bryant</surname><given-names>AL</given-names></name>, <name><surname>Clark</surname><given-names>RA</given-names></name>, <name><surname>Bartold</surname><given-names>S</given-names></name>, <name><surname>Murphy</surname><given-names>A</given-names></name>, <name><surname>Bennell</surname><given-names>KL</given-names></name>, <name><surname>Hohmann</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Effects of estrogen on the mechanical behavior of the human Achilles tendon in vivo</article-title>. <source>J Appl Physiol</source>. <year>2008</year>;<volume>105</volume>(<issue>4</issue>):<fpage>1035</fpage>&#x02013;<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.01281.2007">10.1152/japplphysiol.01281.2007</ext-link></comment>
<pub-id pub-id-type="pmid">18566188</pub-id></mixed-citation></ref><ref id="pone.0197852.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>McMahon</surname><given-names>G</given-names></name>, <name><surname>Morse</surname><given-names>CI</given-names></name>, <name><surname>Burden</surname><given-names>A</given-names></name>, <name><surname>Winwood</surname><given-names>K</given-names></name>, <name><surname>Onamb&#x000e9;l&#x000e9;</surname><given-names>GL</given-names></name>. <article-title>Muscular adaptations and insulin&#x02010;like growth factor&#x02010;1 responses to resistance training are stretch&#x02010;mediated</article-title>. <source>Muscle Nerve</source>. <year>2014</year>;<volume>49</volume>(<issue>1</issue>):<fpage>108</fpage>&#x02013;<lpage>19</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mus.23884">10.1002/mus.23884</ext-link></comment>
<pub-id pub-id-type="pmid">23625461</pub-id></mixed-citation></ref><ref id="pone.0197852.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Reeves</surname><given-names>N</given-names></name>, <name><surname>Maganaris</surname><given-names>C</given-names></name>, <name><surname>Narici</surname><given-names>M</given-names></name>. <article-title>Ultrasonographic assessment of human skeletal muscle size</article-title>. <source>European journal of applied physiology</source>. <year>2004</year>;<volume>91</volume>(<issue>1</issue>):<fpage>116</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00421-003-0961-9">10.1007/s00421-003-0961-9</ext-link></comment>
<pub-id pub-id-type="pmid">14639480</pub-id></mixed-citation></ref><ref id="pone.0197852.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Esformes</surname><given-names>JI</given-names></name>, <name><surname>Narici</surname><given-names>MV</given-names></name>, <name><surname>Maganaris</surname><given-names>CN</given-names></name>. <article-title>Measurement of human muscle volume using ultrasonography</article-title>. <source>European journal of applied physiology</source>. <year>2002</year>;<volume>87</volume>(<issue>1</issue>):<fpage>90</fpage>&#x02013;<lpage>2</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00421-002-0592-6">10.1007/s00421-002-0592-6</ext-link></comment>
<pub-id pub-id-type="pmid">12012082</pub-id></mixed-citation></ref><ref id="pone.0197852.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Reeves</surname><given-names>ND</given-names></name>, <name><surname>Narici</surname><given-names>MV</given-names></name>, <name><surname>Maganaris</surname><given-names>CN</given-names></name>. <article-title>Effect of resistance training on skeletal muscle-specific force in elderly humans</article-title>. <source>J Appl Physiol</source>. <year>2004</year>;<volume>96</volume>(<issue>3</issue>):<fpage>885</fpage>&#x02013;<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00688.2003">10.1152/japplphysiol.00688.2003</ext-link></comment>
<pub-id pub-id-type="pmid">14578365</pub-id></mixed-citation></ref><ref id="pone.0197852.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Pearson</surname><given-names>SJ</given-names></name>, <name><surname>Onambele</surname><given-names>GNL</given-names></name>. <article-title>Influence of time of day on tendon compliance and estimations of voluntary activation levels</article-title>. <source>Muscle Nerve</source>. <year>2006</year>;<volume>33</volume>(<issue>6</issue>):<fpage>792</fpage>&#x02013;<lpage>800</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mus.20529">10.1002/mus.20529</ext-link></comment>
<pub-id pub-id-type="pmid">16523507</pub-id></mixed-citation></ref><ref id="pone.0197852.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Pearson</surname><given-names>SJ</given-names></name>, <name><surname>Onambele</surname><given-names>GNL</given-names></name>. <article-title>Acute changes in knee-extensors torque, fiber pennation, and tendon characteristics</article-title>. <source>Chronobiol Int</source>. <year>2005</year>;<volume>22</volume>(<issue>6</issue>):<fpage>1013</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07420520500397900">10.1080/07420520500397900</ext-link></comment>
<pub-id pub-id-type="pmid">16393705</pub-id></mixed-citation></ref><ref id="pone.0197852.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>McMahon</surname><given-names>GE</given-names></name>, <name><surname>Morse</surname><given-names>CI</given-names></name>, <name><surname>Burden</surname><given-names>A</given-names></name>, <name><surname>Winwood</surname><given-names>K</given-names></name>, <name><surname>Onamb&#x000e9;l&#x000e9;&#x02010;Pearson</surname><given-names>GL</given-names></name>. <article-title>The manipulation of strain, when stress is controlled, modulates in vivo tendon mechanical properties but not systemic TGF&#x02010;&#x003b2;1 levels</article-title>. <source>Physiological reports</source>. <year>2013</year>;<volume>1</volume>(<issue>5</issue>):<fpage>e00091</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/phy2.91">10.1002/phy2.91</ext-link></comment>
<pub-id pub-id-type="pmid">24303165</pub-id></mixed-citation></ref><ref id="pone.0197852.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>LeMoine</surname><given-names>JK</given-names></name>, <name><surname>Lee</surname><given-names>JD</given-names></name>, <name><surname>Trappe</surname><given-names>TA</given-names></name>. <article-title>Impact of sex and chronic resistance training on human patellar tendon dry mass, collagen content, and collagen cross-linking</article-title>. <source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source>. <year>2009</year>;<volume>296</volume>(<issue>1</issue>):<fpage>R119</fpage>&#x02013;<lpage>R24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpregu.90607.2008">10.1152/ajpregu.90607.2008</ext-link></comment>
<pub-id pub-id-type="pmid">18945950</pub-id></mixed-citation></ref><ref id="pone.0197852.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Little</surname><given-names>D</given-names></name>, <name><surname>Thompson</surname><given-names>JW</given-names></name>, <name><surname>Dubois</surname><given-names>LG</given-names></name>, <name><surname>Ruch</surname><given-names>DS</given-names></name>, <name><surname>Moseley</surname><given-names>MA</given-names></name>, <name><surname>Guilak</surname><given-names>F</given-names></name>. <article-title>Proteomic differences between male and female anterior cruciate ligament and patellar tendon</article-title>. <source>PloS one</source>. <year>2014</year>;<volume>9</volume>(<issue>5</issue>):<fpage>e96526</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0096526">10.1371/journal.pone.0096526</ext-link></comment>
<pub-id pub-id-type="pmid">24818782</pub-id></mixed-citation></ref><ref id="pone.0197852.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Knobloch</surname><given-names>K</given-names></name>, <name><surname>Schreibmueller</surname><given-names>L</given-names></name>, <name><surname>Kraemer</surname><given-names>R</given-names></name>, <name><surname>Jagodzinski</surname><given-names>M</given-names></name>, <name><surname>Vogt</surname><given-names>PM</given-names></name>, <name><surname>Redeker</surname><given-names>J</given-names></name>. <article-title>Gender and eccentric training in Achilles mid-portion tendinopathy</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2010</year>;<volume>18</volume>(<issue>5</issue>):<fpage>648</fpage>&#x02013;<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00167-009-1006-7">10.1007/s00167-009-1006-7</ext-link></comment>
<pub-id pub-id-type="pmid">19997901</pub-id></mixed-citation></ref><ref id="pone.0197852.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Hicks</surname><given-names>K</given-names></name>, <name><surname>Onamb&#x000e9;l&#x000e9;</surname><given-names>G</given-names></name>, <name><surname>Winwood</surname><given-names>K</given-names></name>, <name><surname>Morse</surname><given-names>C</given-names></name>. <article-title>Muscle damage following maximal eccentric knee extensions in males and females</article-title>. <source>PloS one</source>. <year>2016</year>;<volume>11</volume>(<issue>3</issue>):<fpage>e0150848</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0150848">10.1371/journal.pone.0150848</ext-link></comment>
<pub-id pub-id-type="pmid">26986066</pub-id></mixed-citation></ref><ref id="pone.0197852.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Goodier</surname><given-names>HC</given-names></name>, <name><surname>Carr</surname><given-names>AJ</given-names></name>, <name><surname>Snelling</surname><given-names>SJ</given-names></name>, <name><surname>Roche</surname><given-names>L</given-names></name>, <name><surname>Wheway</surname><given-names>K</given-names></name>, <name><surname>Watkins</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Comparison of transforming growth factor beta expression in healthy and diseased human tendon</article-title>. <source>Arthritis research &#x00026; therapy</source>. <year>2016</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>.<pub-id pub-id-type="pmid">26732314</pub-id></mixed-citation></ref><ref id="pone.0197852.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Doessing</surname><given-names>S</given-names></name>, <name><surname>Heinemeier</surname><given-names>KM</given-names></name>, <name><surname>Holm</surname><given-names>L</given-names></name>, <name><surname>Mackey</surname><given-names>AL</given-names></name>, <name><surname>Schjerling</surname><given-names>P</given-names></name>, <name><surname>Rennie</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis</article-title>. <source>The Journal of physiology</source>. <year>2010</year>;<volume>588</volume>(<issue>2</issue>):<fpage>341</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">19933753</pub-id></mixed-citation></ref><ref id="pone.0197852.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Bell</surname><given-names>DG</given-names></name>, <name><surname>Jacobs</surname><given-names>I</given-names></name>. <article-title>Electro-mechanical response times and rate of force development in males and females</article-title>. <source>Med Sci Sports Exerc</source>. <year>1986</year>;<volume>18</volume>(<issue>1</issue>):<fpage>31</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">3959861</pub-id></mixed-citation></ref></ref-list></back></article>